2355 Nab-paclitaxel plus gemcitabine or plus simplified LV5FU2 as first- line therapy in patients with metastatic pancreatic adenocarcinoma. A GERCOR randomized phase II study (AFUGEM)
Bachet, J.B, Hammel, P, Desrame, J, Chibaudel, B, Debourdeau, P, Dauba, J, Lecomte, T, Seitz, J.F, Tournigand, C, Aparicio, T, Guerin Meyer, V, Taieb, J, Volet, J, Bonnetain, F, Louvet, C
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2139 CONSIGN: An open-label phase 3B study of regorafenib in patients with metastatic colorectal cancer (mCRC) who failed standard therapy
Van Cutsem, E, Ciardiello, F, Seitz, J.F, Hofheinz, R.D, Verma, U, Garcia-Carbonero, R, Grothey, A, Miriyala, A, Kalmus, J, Shapiro, J, Falcone, A, Zaniboni, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part
Hebbar, M, Heurgue-Berlot, A, Boige, V, Le Malicot, K, Bernard-Chabert, B, Marcus, C, Dharancy, S, Sergent, G, Perarnau, J.M, Ehrhard, F, Ollivier-Hourmand, I, Vergniol, J, Michel, P, Edeline, J, Rinaldi, Y, Seitz, J.F, Lepage, C, De Baere, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2352 Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma: Final results of the SUN-CK phase II trial from GERCOR IRC
Neuzillet, C, Seitz, J.F, Fartoux, L, Malka, D, Lledo, G, Tijeras-Raballand, A, De Gramont, A, Ronot, M, Bouattour, M, Dreyer, C, Granier, M, Benner, S, Amin, A, Bourget, P, Hadengue, A, Roldan, N, Chibaudel, B, Raymond, E, Faivre, S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Revisiting the Multimodal Adjuvant Treatment of Pancreatic Carcinoma Through Optimized Regimen Combining Gemcitabine Plus Oxaliplatin Chemotherapy Followed by Concurrent Gemcitabine and Modern Radiation Therapy -- Long-term Survival Favorable Results
Mornex, F, Andre, T, Louvet, C, Seitz, J.F, Ychou, M, Lledo, G, Tanguy, R, Balosso, J
Published in International journal of radiation oncology, biology, physics (01.11.2012)
Published in International journal of radiation oncology, biology, physics (01.11.2012)
Get full text
Journal Article
177 Lu-Dotatate améliore significativement la survie sans progression des patients atteints de tumeurs neuroendocrines métastatiques progressives de l’intestin moyen : résultats de l’essai de phase III NETTER-1
Ruszniewski, P, Courbon, F, Lebtahi, R, Giammarile, F, Lombard-Bohas, C, Ansquer, C, Matysiac, T, Guimbaud, R, Taieb, D, Seitz, J.F, Ducreux, M, Baudin, E, Yao, J.C, Hendifar, A, Krenning, E, Strosber, J
Published in Annales d'endocrinologie (01.09.2016)
Published in Annales d'endocrinologie (01.09.2016)
Get full text
Journal Article
6575 Bevacizumab combined with chemotherapy in the treatment of advanced/metastatic gastro-entero-pancreatic tumours: interim safety results from the phase II BETTER study
Mitry, E, Ducreux, M, Dominguez, S, Louvet, C, Seitz, J.F, Smith, D, Kurtz, J.E, Lombard-Bohas, C, Ruszniewski, P, O'Toole, D
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
3540 POSTER Postoperative adjuvant gemcitabine plus oxaliplatin (GemOx) chemotherapy followed by chemoradiation in patients with pancreatic carcinoma: mature results of a multicenter phase II study
Mornex, F, Andre, T, Louvet, C, Seitz, J.F, Ychou, M, Lledo, G, Balosso, J, Partensky, C
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
Aparicio, T., Lavau-Denes, S., Phelip, J.M., Maillard, E., Jouve, J.L., Gargot, D., Gasmi, M., Locher, C., Adhoute, X., Michel, P., Khemissa, F., Lecomte, T., Provençal, J., Breysacher, G., Legoux, J.L., Lepère, C., Charneau, J., Cretin, J., Chone, L., Azzedine, A., Bouché, O., Sobhani, I., Bedenne, L., Mitry, E., Amoyal, P., Auby, D., Bachet, J.B., Baconnier, M., Benoit, R., Berthelet, O., Bidault, A., Bineau, C., Bordes, G., Bouarioua, N., Boucher, E., Boulat, O., Cleau, D., Couzigou, P., Cuillerier, E., Cumin, I., Denis, B., Di Fiore, F., Derias, V., Ezenfis, J., Faroux, R., Gagnaire, A., Gatineau-Sailliant, G., Garcia, B., Genet, D., Gueye, A., Hammel, P., Lagasse, J.P., Landi, B., Lepage, C., Lobry, C., Lombard-Bohas, C., Mabro, M., Mackiewicz, R., Martin, J., Moncoucy, X., Morvan, F., Mozer, M., Pauwels, M., Petit-Laurent, F., Pouderoux, P., Prost, P., Queuniet, A.M., Ramdani, M., Rebischung, C., Rougier, P., Schnee, M., Seitz, J.F., Stefani, L., Taïeb, J., Terrebonne, E., Texereau, P., Thaury, J., Tougeron, D., Weber, A., Ricard, F., Bonnetain, F., Masskouri, F., Choine, C., Guiliani, F., Le Pessec, G., Fattouh, H., Le Provost, N., Girault, C., Schneider, M.
Published in Annals of oncology (01.01.2016)
Published in Annals of oncology (01.01.2016)
Get full text
Journal Article
Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)
Veziant, Julie, Bouché, Olivier, Aparicio, T, Barret, M, El Hajbi, F, Lepilliez, V, Lesueur, P, Maingon, P, Pannier, D, Quero, L, Raoul, J L, Renaud, F, Seitz, J F, Serre, A A, Vaillant, E, Vermersch, M, Voron, T, Tougeron, D, Piessen, Guillaume
Published in Digestive and liver disease (01.12.2023)
Published in Digestive and liver disease (01.12.2023)
Get full text
Journal Article
Impact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trial
Valerie, B., Mollevi, C., Chaput, N., Gourgou, S., Azria, D., Seitz, J.F., Bigot, L., Juzyna, B., Miran, I., Gérard, J-P., Laurent-Puig, P.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)
Bouché, O., Ychou, M., Burtin, P., Bedenne, L., Ducreux, M., Lebreton, G., Baulieux, J., Nordlinger, B., Martin, C., Seitz, J. F., Tigaud, J. M., Echinard, E., Stremsdoerfer, N., Milan, C., Rougier, P.
Published in Annals of oncology (01.09.2005)
Published in Annals of oncology (01.09.2005)
Get full text
Journal Article
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
Mitry, Emmanuel, Hammel, Pascal, Deplanque, Gaël, Mornex, Françoise, Levy, Philippe, Seitz, Jean-François, Moussy, Alain, Kinet, Jean-Pierre, Hermine, Olivier, Rougier, Philippe, Raymond, Eric
Published in Cancer chemotherapy and pharmacology (01.07.2010)
Published in Cancer chemotherapy and pharmacology (01.07.2010)
Get full text
Journal Article
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population
Renfro, L.A., Grothey, A., Kerr, D., Haller, D.G., André, T., Van Cutsem, E., Saltz, L., Labianca, R., Loprinzi, C.L., Alberts, S.R., Schmoll, H., Twelves, C., Yothers, G., Sargent, D.J., Sargent, D.J., Green, E., Grothey, A., Alberts, S.R., Shi, Q., Renfro, L.A., Yothers, G., O'Connell, M.J., Wolmark, N., de Gramont, A., Gray, R., Kerr, D., Haller, D.G., Guthrie, K., Buyse, M., Labianca, R., Seitz, J.F., O'Callaghan, C.J., Francini, G., Catalano, P.J., Blanke, C.D., Andre, T., Goldberg, R.M., Benson, A., Twelves, C., Sirzen, F., Cisar, L., Van Cutsem, E., Saltz, L.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France
Lombard-Bohas, C., Mitry, E., O’Toole, D., Louvet, C., Pillon, D., Cadiot, G., Borson-Chazot, F., Aparicio, T., Ducreux, M., Lecomte, T., Etienne, P.L., Cacheux, W., Legoux, J.L., Seitz, J.F., Ruszniewski, P., Chayvialle, J.A., Rougier, P.
Published in Neuroendocrinology (01.02.2009)
Published in Neuroendocrinology (01.02.2009)
Get full text
Journal Article
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors
Ychou, M., Conroy, T., Seitz, J. F., Gourgou, S., Hua, A., Mery-Mignard, D., Kramar, A.
Published in Annals of oncology (01.03.2003)
Published in Annals of oncology (01.03.2003)
Get full text
Journal Article
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
Ducreux, M., Mitry, E., Ould-Kaci, M., Boige, V., Seitz, J. F., Bugat, R., Breau, J. L., Bouché, O., Etienne, P. L., Tigaud, J. M., Morvan, F., Cvitkovic, E., Rougier, P.
Published in Annals of oncology (01.03.2004)
Published in Annals of oncology (01.03.2004)
Get full text
Journal Article
Final results of a randomised trial comparing ‘Tomudex’ (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
Cunningham, D., Zalcberg, J. R., Rath, U., Oliver, I., van Cutsem, E., Svensson, C., Seitz, J. F., Harper, P., Kerr, D., Perez-Manga, G.
Published in Annals of oncology (01.11.1996)
Published in Annals of oncology (01.11.1996)
Get full text
Journal Article
Essai de phase II randomisé de chimioradiothérapie exclusive avec ou sans escalade de dose chez des patients atteints de cancer de l’œsophage : concorde (Prodige 26)
Créhange, G., Bertaut, A., Le Prisé, É., Étienne, P.L., Rio, E., Pereira, R., Noêl, G., Bénézery, K., Seitz, J.F., Bonnetain, F., Peiffert, D.
Published in Cancer radiothérapie (01.10.2017)
Published in Cancer radiothérapie (01.10.2017)
Get full text
Journal Article
Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting
Douillard, J.Y., Tilleul, P., Ychou, M., Dufour, P., Perrocheau, G., Seitz, J.F., Maes, P., Lafuma, A., Husseini, F.
Published in Oncology (01.01.2007)
Published in Oncology (01.01.2007)
Get full text
Journal Article